rs142637231
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000369406.8(HMGCS2):c.862C>T(p.Arg288Ter) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,613,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R288R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000369406.8 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HMGCS2 | NM_005518.4 | c.862C>T | p.Arg288Ter | stop_gained | 5/10 | ENST00000369406.8 | NP_005509.1 | |
HMGCS2 | NM_001166107.1 | c.736C>T | p.Arg246Ter | stop_gained | 4/9 | NP_001159579.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HMGCS2 | ENST00000369406.8 | c.862C>T | p.Arg288Ter | stop_gained | 5/10 | 1 | NM_005518.4 | ENSP00000358414 | P1 | |
HMGCS2 | ENST00000544913.2 | c.736C>T | p.Arg246Ter | stop_gained | 4/9 | 2 | ENSP00000439495 | |||
HMGCS2 | ENST00000472375.5 | n.309C>T | non_coding_transcript_exon_variant | 2/3 | 5 | |||||
HMGCS2 | ENST00000476640.1 | n.593C>T | non_coding_transcript_exon_variant | 3/4 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152130Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000398 AC: 1AN: 251136Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135710
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1461522Hom.: 0 Cov.: 32 AF XY: 0.00000138 AC XY: 1AN XY: 727106
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74314
ClinVar
Submissions by phenotype
3-hydroxy-3-methylglutaryl-CoA synthase deficiency Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 27, 2023 | This sequence change creates a premature translational stop signal (p.Arg288*) in the HMGCS2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HMGCS2 are known to be pathogenic (PMID: 20346956, 23751782, 25511235). This variant is present in population databases (rs142637231, gnomAD 0.005%). This premature translational stop signal has been observed in individual(s) with clinical features of HMGCS2-related conditions (PMID: 30283815, 32259399). ClinVar contains an entry for this variant (Variation ID: 280473). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 26, 2021 | - - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Mar 21, 2018 | The R288X variant in the HMGCS gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The R288X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016). We interpret R288X as a pathogenic variant. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at